# Celltrion signs $1.9B contract to supply COVID-19 test kits to US distributor

Celltrion USA signed a contract with Prime Healthcare Distributors to supply its Sampinute COVID-19 rapid antigen test kits across the United States. The deal is valued at 210 billion won (approximately $1.9 billion) and grants Prime Healthcare exclusive distribution rights.

- Type: Contract
- Announced: 2020-11-02
- Where: United States
- Value: $190.0M (210.0B KRW)
- Status: announced
- Products: COVID-19 rapid antigen test kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Celltrion](https://endata.com/companies/15585.md)
- [Prime Healthcare Distributors](https://endata.com/companies/50908.md) (customer)

## Sources

- [health.chosun.com](https://health.chosun.com/site/data/html_dir/2020/11/02/2020110201020.html), 2020-11-02: "셀트리온 USA는 미국 프라임 헬스케어 디스트리뷰터스(Prime Healthcare Distributors)사와 2100억원 규모 코로나19 진단키트 공급 계약을 체결했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.